Evaluating the Potential of Plukenetia volubilis Linneo (Sacha Inchi) in Alleviating Cardiovascular Disease Risk Factors: A Mini Review

被引:4
|
作者
Abd Rahman, Izzat Zulhilmi [1 ]
Nor Hisam, Nur Syahidah [1 ,2 ]
Aminuddin, Amilia [1 ]
Hamid, Adila A. [1 ]
Kumar, Jaya [1 ]
Ugusman, Azizah [1 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Jalan Yaacob Latif, Cheras 56000, Kuala Lumpur, Malaysia
[2] Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Toxicol & Hlth Risk Studies, Programme Biomed Sci, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia
关键词
antioxidant; cholesterol; diabetes; inflammation; obesity; Plukenetia volubilis Linneo; sacha inchi; HIGH-FAT DIET; OXIDATIVE STRESS; BIOLOGICAL-ACTIVITY; GUT MICROBIOTA; NITRIC-OXIDE; L; ALPHA; ACIDS; HYPERTENSION; METABOLISM;
D O I
10.3390/ph16111588
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Plukenetia volubilis Linneo or Sacha Inchi (SI), a traditional natural remedy indigenous to Peru and Brazil, has garnered global attention due to its exceptional nutritional composition. Its protective effects against various non-communicable diseases, notably cardiovascular disease (CVD), have become a subject of interest in recent research. This comprehensive review summarizes the existing evidence from 15 relevant articles concerning the impact of SI on common CVD risk factors, including dyslipidemia, obesity, diabetes, and hypertension. The relevant articles were derived from comprehensive searches on PubMed, Scopus, Google Scholar, and Web of Science using predefined criteria and keywords related to the topic. Overall, SI demonstrated positive effects in attenuating dyslipidemia, obesity, diabetes, and hypertension. The multifaceted mechanisms responsible for the protective effects of SI against these CVD risk factors are primarily attributed to its antioxidative and anti-inflammatory properties. While preclinical studies dominate the current scientific literature on SI, there are limited clinical trials to corroborate these findings. Therefore, future well-designed, large-scale randomized clinical trials are highly recommended to establish the efficacy of SI and determine its optimal dosage, potential drug and food interactions, and practical integration into preventive strategies and dietary interventions for the high-risk populations.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Prevalence of Cardiovascular Disease Risk Factors in the Gambia: A Systematic Review
    Koller, Robin
    Agyemang, Charles
    GLOBAL HEART, 2020, 15 (01)
  • [32] Childhood Risk Factors and Adulthood Cardiovascular Disease: A Systematic Review
    Pool, Lindsay R.
    Aguayo, Liliana
    Brzezinski, Michal
    Perak, Amanda M.
    Davis, Matthew M.
    Greenland, Philip
    Hou, Lifang
    Marino, Bradley S.
    Van Horn, Linda
    Wakschlag, Lauren
    Labarthe, Darwin
    Lloyd-Jones, Donald
    Allen, Norrina B.
    JOURNAL OF PEDIATRICS, 2021, 232 : 118 - +
  • [33] The impact of imprisonment on cardiovascular disease risk factors: a systematic review
    Bondolfi, C.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 178 - 178
  • [34] TRADITIONAL CARDIOVASCULAR RISK FACTORS AND THE RISK OF AORTIC VALVE DISEASE: A SYSTEMATIC REVIEW
    Wang, Michael K.
    Lam, Gabriel
    Lamelas, Pablo
    Brual, Xyza
    Al-Saleh, Ayman
    Natarajan, Madhu
    Teo, Koon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 2089 - 2089
  • [35] CARDIOVASCULAR DISEASE RISK AND RISK FACTORS ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIA: A SYSTEMATIC REVIEW
    Kruse, G.
    Kutikova, M.
    Wong, B.
    Villa, G.
    Ray, K. K.
    Mata, P.
    Bruckert, E.
    VALUE IN HEALTH, 2017, 20 (09) : A606 - A606
  • [36] Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: Is there potential for adverse events? A systematic review of the literature
    Villani, Anthony M.
    Crotty, Maria
    Cleland, Leslie G.
    James, Michael J.
    Fraser, Robert J.
    Cobiac, Lynne
    Miller, Michelle D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4371 - 4375
  • [37] Potential cardiovascular risk factors in patients with end stage renal disease
    Perovic, M
    Stankovic, S
    CLINICA CHIMICA ACTA, 2005, 355 : S183 - S183
  • [38] PPARγ Agonists and Vascular Risk Factors: Potential Effects on Cardiovascular Disease
    Asnani, Sunil
    Theuma, Pierre
    Fonseca, Vivian A.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2003, 1 (01) : 23 - 32
  • [39] The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review
    Juan Sanchez-Ramos
    Shijie Song
    Chuanhai Cao
    Gary Arendash
    BMC Neuroscience, 9
  • [40] The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review
    Sanchez-Ramos, Juan
    Song, Shijie
    Cao, Chuanhai
    Arendash, Gary
    BMC NEUROSCIENCE, 2008, 9 (Suppl 2)